Department of Clinical Medicine and Surgery, Federico II University Medical School of Naples, Naples, Italy.
Department of Life, Health and Environmental Sciences‑MESVA, School of Emergency‑Urgency Medicine, University of L'Aquila, 67100, L'Aquila, Italy.
Intern Emerg Med. 2023 Oct;18(7):1887-1895. doi: 10.1007/s11739-023-03339-z. Epub 2023 Jul 25.
Sarcopenia is a severe condition common to various chronic diseases and it is reckoned as a major health problem. It encompasses many different molecular mechanisms that have been for a while discovered but not definitely clarified. Although sarcopenia is a disability status that leads to serious health consequences, the scarcity of suitable animal models has curtailed research addressing this disorder. Another limitation in the field of clinical investigation of sarcopenic patients is the lack of a generally accepted definition coupled with the difficulty of adopting common diagnostic criteria. In fact, both do not permit to clarify the exact prevalence rate and consequently limit physicians to establish any kind of therapeutical approach or, when possible, to adopt preventive measures. Unfortunately, there is no standardized cure, apart from doing more physical activity and embracing a balanced diet, but newly discovered substances start being considered. In this review, authors try to give an overview addressing principal pathways of sarcopenia and offer critical features of various possible interventions.
肌肉减少症是多种慢性疾病中常见的严重病症,被认为是一个主要的健康问题。它包含许多不同的分子机制,这些机制已经被发现了一段时间,但尚未得到明确阐明。尽管肌肉减少症是一种导致严重健康后果的残疾状态,但缺乏合适的动物模型限制了对这种疾病的研究。肌肉减少症患者临床研究领域的另一个限制是缺乏普遍接受的定义,加上采用共同诊断标准的困难。事实上,这两者都不能明确确切的患病率,因此限制了医生采用任何治疗方法,或者在可能的情况下采取预防措施。不幸的是,除了多做运动和均衡饮食之外,目前还没有标准化的治疗方法,但新发现的物质开始被考虑。在这篇综述中,作者试图概述肌肉减少症的主要途径,并提供各种可能干预措施的关键特征。